Editorial Comment: LI-RADS LR-2 and LR-3 Observations-Benign or Not Benign?

An Tang¹

Affiliations

Editorial

An Tang. AJR Am J Roentgenol. 2022 Mar.

. 2022 Mar;218(3):471.

doi: 10.2214/AJR.21.27014. Epub 2021 Nov 3.

An Tang¹

¹ Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada an.tang@umontreal.ca.

No abstract available

Comment on

Progression Rates of LR-2 and LR-3 Observations on MRI to Higher LI-RADS Categories in Patients at High Risk of Hepatocellular Carcinoma: A Retrospective Study.
Ranathunga D, Osman H, Islam N, McInnes MDF, Munir J, van der Pol CB, Elfaal M, Walsh C. Ranathunga D, et al. AJR Am J Roentgenol. 2022 Mar;218(3):462-470. doi: 10.2214/AJR.21.26376. Epub 2021 Oct 13. AJR Am J Roentgenol. 2022. PMID: 34643108